Oligo sequences for competition library: Human SLC25A40 sg1 F: caccGGTTGGATTTCCCTTTGGAG, sg1 R: aaacCTCCAAAGGGAAATCCAACC, sg5 F: caccgAAGAGGGAGGCAACAAACTA, sg5 R: aaacTAGTTTGTTGCCTCCCTCTTc, sg6 F: caccgAAGAAGCCAGGAAATTTCCA, sg6 R: aaacTGGAAATTTCCTGGCTTCTTc, sg7 F: caccGGTACATCTCTAAGAACAGT, sg7 R: aaacACTGTTCTTAGAGATGTACC, sg8 F: caccgCTATGTGTCTGTGAAGAGGG, sg8 R: aaacCCCTCTTCACAGACACATAGc, Human TXNRD2 sg2 F: caccgTAAACCACTGGAGTTCACGG, sg2 R: aaacCCGTGAACTCCAGTGGTTTAc, sg3 F: caccGATTAGGAGGGCGCTTCCGG, sg3 R: aaacCCGGAAGCGCCCTCCTAATC, sg6 F: caccgCAAGAAGCTGATGCACCAGG, sg6 R: aaacCCTGGTGCATCAGCTTCTTGc, sg7 F: caccGCACTACCTGGTCGAAGCCG, sg7 R: aaacCGGCTTCGACCAGGTAGTGC, sg8 F: caccGGAGGACAGCACCACCGGCA, sg8 R: aaacTGCCGGTGGTGCTGTCCTCC, Control sg5 F: GCGGATTAGAGGTAATGCGG, sg5 R: CCGCATTACCTCTAATCCGC, sg6 F: GGAGCCATGGTAGAGCGTAT, sg6 R: ATACGCTCTACCATGGCTCC, sg11 F: GGCGCTCGATTAAGACTCAG, sg11 R: CTGAGTCTTAATCGAGCGCC, sg12 F: GTTACGCGTGCTGTCGCTTC, sg12 R: GAAGCGACAGCACGCGTAAC, sg13 F: GTTCCTTCTGCAGGCACGCT, sg13 R: AGCGTGCCTGCAGAAGGAAC Analysis of transcriptome-wide association studies (TWAS) data We analyzed transcriptome-wide association studies (TWAS) results on 4,000 traits for SLC25A39 in the UK Biobank 12 (n=361,194) using the summary-statistics-based, joint-tissue PrediXcan 51,52
Rather than relying on stimulants or crash diets, it leverages a blend of metabolism-supporting nutrients to trigger sustained fat oxidation with just a glass of cold water and one capsule per day
In four of them, compared with the placebo group, a significant decrease in glucose levels was observed after L-carnitine administration.[ , , , ] Moreover, six studies indicated a contrast reporting no significant change in glucose levels compared with the placebo group.[ , , , , , , ] Also, one paper indicated no statistically notable change in PPG and FPI in comparison to the placebo group after 6 months.[] Moreover, all of the eight studies that evaluated the HbA1C level showed that it did not have any significant change after the intervention when compared with the placebo group.[ , , , , , , , , ] Therefore, according to our results, supplementation of L-carnitine does not have any short-term or long-term effects on glycemic control
Sameer Murali, MD, the medical director of obesity medicine at Memorial Hermann Health System
